Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Green Cap Health vs TrueMe

Green Cap Health
Graded #227

Lower grade

vs+2.299999999999997
TrueMe
Graded #169

Higher grade

The verdict

TrueMe takes it — 67.6/100 to 65.3/100.

TrueMe grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TrueMe is a cash-pay telehealth brand offering compounded semaglutide and tirzepatide with added B vitamins, alongside NAD+, sermorelin and glutathione.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGreen Cap Health +18
80
62
Dose & formulationTrueMe +13
64
77
Clinical oversightTrueMe +10
68
78
Labs & monitoringEven
52
52
FulfillmentTrueMe +25
56
81
Contract termsGreen Cap Health +10
55
45
Green Cap Health · left barTrueMe · right bar

The numbers

MetricGreen Cap HealthTrueMe
WeighScore65.3/10067.6/100
GradeCC
Scorecard rank#227#169
Semaglutide$79/mo (starting dose, first-month rate, compounded)$159/mo (compounded)
Tirzepatide$119/mo (starting dose, compounded)$189/mo (compounded)
Coverage1 states6 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Green Cap Health

Graded #227 · C

Strengths

  • Vertically integrated — it is both the clinical practice and its own 503A Texas compounding pharmacy, a clear supply chain
  • Aggressive $79 first-month intro pricing, competitive despite being Texas-only
  • Texas patients can consolidate GLP-1, hair, skin, and sexual wellness under one practice
  • Phone support published with a Houston area code
  • Same-day provider review, faster than 24–48hr competitors

Where it loses points

  • Texas only — patients in the other 49 states and DC can't use it
  • No tirzepatide — semaglutide only, so those wanting the higher-magnitude option must look elsewhere
  • LegitScript certification status not disclosed
  • No named medical director — only "doctors, nurse practitioners, and pharmacists"
  • FDA compounded-medication disclaimer not visible on the homepage
TrueMe

Graded #169 · C

Strengths

  • One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
  • Same price at every dose, so the cost does not climb as a provider titrates the dose upward
  • Full pricing is published up front — no intake form is required before you can see what you will pay
  • Carries a genuine LegitScript-issued seal (ID 50205625) that resolves on LegitScript's own asset host
  • Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas

Where it loses points

  • Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
  • Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
  • You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
  • The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
  • A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard